[1]
Klunko, N. 2021. Resource support of adaptation capabilities of the pharmaceutical industry under COVID-19 pandemic. Technology audit and production reserves. 2, 4(58) (Apr. 2021), 6–11. DOI:https://doi.org/10.15587/2706-5448.2021.230581.